Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs

医学 心脏病学 烧蚀 内科学 室性心动过速 心动过速 麻醉 导管消融
作者
John L. Sapp,George A. Wells,Ratika Parkash,William G. Stevenson,Louis E. Blier,JEAN‐FRANÇOIS SARRAZIN,Bernard Thibault,Léna Rivard,Lorne J. Gula,Peter Leong‐Sit,Vidal Essebag,Pablo B. Nery,Stanley Tung,Jean‐Marc Raymond,Laurence D. Sterns,George D. Veenhuyzen,Jeff S. Healey,Damian Redfearn,Jean-François Roux,ANTHONY S.L. TANG
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:375 (2): 111-121 被引量:910
标识
DOI:10.1056/nejmoa1513614
摘要

BACKGROUND: Recurrent ventricular tachycardia among survivors of myocardial infarction with an implantable cardioverter-defibrillator (ICD) is frequent despite antiarrhythmic drug therapy. The most effective approach to management of this problem is uncertain. METHODS: We conducted a multicenter, randomized, controlled trial involving patients with ischemic cardiomyopathy and an ICD who had ventricular tachycardia despite the use of antiarrhythmic drugs. Patients were randomly assigned to receive either catheter ablation (ablation group) with continuation of baseline antiarrhythmic medications or escalated antiarrhythmic drug therapy (escalated-therapy group). In the escalated-therapy group, amiodarone was initiated if another agent had been used previously. The dose of amiodarone was increased if it had been less than 300 mg per day or mexiletine was added if the dose was already at least 300 mg per day. The primary outcome was a composite of death, three or more documented episodes of ventricular tachycardia within 24 hours (ventricular tachycardia storm), or appropriate ICD shock. RESULTS: Of the 259 patients who were enrolled, 132 were assigned to the ablation group and 127 to the escalated-therapy group. During a mean (±SD) of 27.9±17.1 months of follow-up, the primary outcome occurred in 59.1% of patients in the ablation group and 68.5% of those in the escalated-therapy group (hazard ratio in the ablation group, 0.72; 95% confidence interval, 0.53 to 0.98; P=0.04). There was no significant between-group difference in mortality. There were two cardiac perforations and three cases of major bleeding in the ablation group and two deaths from pulmonary toxic effects and one from hepatic dysfunction in the escalated-therapy group. CONCLUSIONS: In patients with ischemic cardiomyopathy and an ICD who had ventricular tachycardia despite antiarrhythmic drug therapy, there was a significantly lower rate of the composite primary outcome of death, ventricular tachycardia storm, or appropriate ICD shock among patients undergoing catheter ablation than among those receiving an escalation in antiarrhythmic drug therapy. (Funded by the Canadian Institutes of Health Research and others; VANISH ClinicalTrials.gov number, NCT00905853.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
传奇3的应助被yy采纳,获得10
1秒前
帅气的Bond发布了新的文献求助10
1秒前
Akim的应助被fdaf采纳,获得10
1秒前
Novo发布了新的文献求助10
2秒前
奔跑的应助被yangyang采纳,获得10
3秒前
海里完成签到,获得积分20
3秒前
3秒前
李爱国的应助被文静的海采纳,获得10
3秒前
3秒前
4秒前
Clover04的应助被无情的人达采纳,获得10
4秒前
luyue9406的应助被无情的人达采纳,获得10
4秒前
孟喆完成签到,获得积分10
4秒前
青岛彭于晏完成签到,获得积分10
5秒前
5秒前
dan1029发布了新的文献求助10
5秒前
LCC完成签到,获得积分10
5秒前
6秒前
HQKing完成签到,获得积分10
6秒前
廖怡宣发布了新的文献求助10
6秒前
ccc完成签到,获得积分10
7秒前
牛C完成签到,获得积分10
7秒前
小岭发布了新的文献求助50
7秒前
8秒前
阳光代容发布了新的文献求助10
8秒前
可爱的函函的应助被xucc采纳,获得10
8秒前
落后十八发布了新的文献求助10
9秒前
9秒前
9秒前
帅气的Bond完成签到,获得积分20
9秒前
小羊发布了新的文献求助10
9秒前
思源的应助被别云间采纳,获得10
9秒前
9秒前
谨慎鞅完成签到,获得积分10
9秒前
挚友发布了新的文献求助20
9秒前
quuy完成签到,获得积分10
10秒前
千陽发布了新的文献求助10
11秒前
0529发布了新的文献求助10
11秒前
冲冲冲发布了新的文献求助10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175707
求助须知:如何正确求助?哪些是违规求助? 9567353
关于积分的说明 21792214
捐赠科研通 7770334
什么是DOI,文献DOI怎么找? 3431908
关于科研通互助平台的介绍 2556260
邀请新用户注册赠送积分活动 2477417